Insider Trading Summary for Apellis Pharmaceuticals, Inc. (APLS): Three Months

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Jan-23 5:33 PM View:	01-Jan-23 Grant 0	Chan Gerald Director		Apellis Pharmaceuticals, Inc. - APLS	91% 4.23K to 8.1K	0	0	--	--	Show Txns Hide Txns

05-Jan-23 7:40 PM View:	03-Jan-23 Private Sale (Planned) ($25.35K)	Dunlop A. Sinclair Director		Apellis Pharmaceuticals, Inc. - APLS	1% 402.46K to 405.33K	0	0	--	--	Show Txns Hide Txns

19-Jan-23 4:55 PM View:	17-Jan-23 Planned Option Sale ($65.52K)	MacHiels Alec Director		Apellis Pharmaceuticals, Inc. - APLS	1% 675.72K to 679.59K	0	0	--	--	Show Txns Hide Txns

04-Jan-23 5:33 PM View:	01-Jan-23 Grant 0	O'Brien Stephanie Monaghan Director		Apellis Pharmaceuticals, Inc. - APLS	91% 4.23K to 8.1K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 5:19 PM View:	27-Jan-23 Payment of Exercise ($29.08K)	Watson David O. General Counsel		Apellis Pharmaceuticals, Inc. - APLS	41% 125.57K to 176.44K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 5:05 PM View:	27-Jan-23 Payment of Exercise ($29.08K)	Sullivan Timothy Eugene Chief Financial Officer		Apellis Pharmaceuticals, Inc. - APLS	25% 99.65K to 124.21K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 4:59 PM View:	27-Jan-23 Payment of Exercise ($151.92K)	Francois Cedric Chief Executive Officer Director		Apellis Pharmaceuticals, Inc. - APLS	6% 1.48M to 1.57M	0	0	--	--	Show Txns Hide Txns

04-Jan-23 5:31 PM View:	01-Jan-23 Grant 0	Fonteyne Paul R. Director		Apellis Pharmaceuticals, Inc. - APLS	42% 9.23K to 13.1K	0	0	--	--	Show Txns Hide Txns

24-Jan-23 4:57 PM View:	20-Jan-23 Payment of Exercise ($73.49K)	Brown Victoria L. Program Team Lead		Apellis Pharmaceuticals, Inc. - APLS	(6%) 24.97K to 23.56K	0	0	--	--	Show Txns Hide Txns

31-Jan-23 4:47 PM View:	30-Jan-23 Private Sale (Planned) ($46.59K)	Lewis Karen Chief People Officer		Apellis Pharmaceuticals, Inc. - APLS	62% 22.44K to 36.46K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 5:02 PM View:	27-Jan-23 Payment of Exercise ($29.08K)	Nicholson Nur Chief Technical Officer		Apellis Pharmaceuticals, Inc. - APLS	58% 34.45K to 54.44K	0	0	--	--	Show Txns Hide Txns

09-Jan-23 7:02 PM View:	05-Jan-23 Private Sale (Planned) ($121.98K)	Grossi Federico CHIEF MEDICAL OFFICER		Apellis Pharmaceuticals, Inc. - APLS	(5%) 99.88K to 94.88K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 4:47 PM View:	27-Jan-23 Payment of Exercise ($43.90K)	Deschatelets Pascal Chief Scientific Officer		Apellis Pharmaceuticals, Inc. - APLS	4% 957.28K to 1.0M	0	0	--	--	Show Txns Hide Txns

30-Jan-23 5:07 PM View:	27-Jan-23 Payment of Exercise ($29.08K)	Townsend Adam J. Chief Commercial Officer		Apellis Pharmaceuticals, Inc. - APLS	28% 52.91K to 67.93K	0	0	--	--	Show Txns Hide Txns

24-Jan-23 4:58 PM View:	20-Jan-23 Payment of Exercise ($47.83K)	Chopas James George VP/Chief Accounting Officer		Apellis Pharmaceuticals, Inc. - APLS	47% 18.45K to 27.15K	0	0	--	--	Show Txns Hide Txns

05-Jan-23 10:00 PM View:	03-Jan-23 Grant 0	Baumal Caroline Chief Medical Officer		Apellis Pharmaceuticals, Inc. - APLS	26729% 0.13K to 35.68K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 4:45 PM View:	27-Jan-23 Payment of Exercise ($19.37K)	Delong Mark Jeffrey Chief Business & Strat Officer		Apellis Pharmaceuticals, Inc. - APLS	62% 29.05K to 47.17K	0	0	--	--	Show Txns Hide Txns

31-Jan-23 4:51 PM View:	30-Jan-23 Private Sale (Planned) ($46.59K)	Eisele Jeffrey Chief Development Officer		Apellis Pharmaceuticals, Inc. - APLS	46% 31.74K to 46.47K	0	0	--	--	Show Txns Hide Txns

30-Jan-23 5:03 PM View:	27-Jan-23 Payment of Exercise ($28.60K)	Scheibler Lukas Chief Research Officer		Apellis Pharmaceuticals, Inc. - APLS	49% 41.13K to 61.15K	0	0	--	--	Show Txns Hide Txns

Apellis Pharmaceuticals, Inc. (APLS)

Last Three Months

03-Nov-22 -- 02-Feb-23

Company Sentiment

Other

Other

Two Year Chart

03-Feb-21 -- 02-Feb-23

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--